A detailed history of Darwin Global Management, Ltd. transactions in Insmed Inc stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 15,397,975 shares of INSM stock, worth $1.09 Billion. This represents 81.63% of its overall portfolio holdings.

Number of Shares
15,397,975
Previous 12,960,538 18.81%
Holding current value
$1.09 Billion
Previous $895 Million 31.28%
% of portfolio
81.63%
Previous 84.75%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$65.25 - $83.83 $159 Million - $204 Million
2,437,437 Added 18.81%
15,397,975 $1.17 Billion
Q4 2024

Feb 14, 2025

BUY
$66.29 - $76.63 $163 Million - $189 Million
2,463,261 Added 23.47%
12,960,538 $895 Million
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $431 Million - $550 Million
6,956,182 Added 196.44%
10,497,277 $766 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $77.9 Million - $247 Million
3,541,095 New
3,541,095 $237 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.58B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Darwin Global Management, Ltd. Portfolio

Follow Darwin Global Management, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Darwin Global Management, Ltd. with notifications on news.